MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

MS is a chronic disease with no cure. It varies quite a bit from person to person, and most people with MS will not develop end stage MS. For some people, MS can lead to severe disabilities and ...

A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) with generous support from EMD Serono's Embracing Caregivers initiative, announced today ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple ...